Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort ascending
Jan
26
2022
Federal Circuit Drills Down on Ordinary Skill Requirement in Vacating ITC Infringement Determination Finnegan
Feb
26
2021
Spotlight on Upcoming Oral Arguments - March 2021 Finnegan
Apr
7
2021
Federal Circuit Confirms the PTAB’s Authority to Deinstitute IPR Proceedings Finnegan
Apr
26
2021
Spotlight on Upcoming Oral Arguments – May 2021 Finnegan
Jun
29
2021
TTAB Trims Monster’s Claws by Dismissing Opposition Against Toronto Raptors Logo Finnegan
Jul
9
2021
German Constitutional Court Provides a Green Light for the UPC to Proceed Finnegan
Jul
29
2021
Second Circuit Holds that Billions’ Legal Drama Will Stay Only Onscreen Finnegan
Aug
2
2021
Clarifying Pleading Requirements for Patent Cases Finnegan
Aug
20
2021
Blocking Patents: A Patent Cannot Block Itself Finnegan
Aug
26
2021
All the Expenses of the Proceedings, Just Not Expert Witness Fees Finnegan
Sep
21
2021
Predictably, a Funny Thing Happened on the Way to the PTAB FWD - Part 1: Merck Overcomes Inherent Anticipation Challenge at the PTAB Finnegan
Oct
1
2021
Bad Acts and Actors Never Die; They Simply Lose Their Appeal Finnegan
Oct
29
2021
Staying on Track With Your U.S. Patent Finnegan
Nov
22
2021
California District Court Says Cuozzo Bars NHK-Fintiv Challenges Finnegan
Nov
29
2021
Federal Circuit Disinfects PTAB’s Obviousness Finding for MRSA Inactivation Patent Finnegan
Dec
3
2021
Second Arthrex Petition Granted to Vacate PTAB Decision Finnegan
Dec
13
2021
First Sale Doctrine Fails to Free Unauthorized Online Retailer from Infringement Claims Finnegan
Dec
20
2021
Moderna’s Appeal of PTAB Decision Dismissed for Lack of Standing Finnegan
Feb
24
2021
Podcast Series: Last Month at the Federal Circuit - February 2021 Finnegan
Mar
5
2021
Sanctions Imposed Against Litigant for “Abusive” Litigation Conduct Finnegan
Mar
17
2021
In Rare Sua Sponte Order, PTAB Finds Using a Trademark Could Render Claim Indefinite Finnegan
Apr
7
2021
A Real Party-in-Interest Determination is Final and Non-Appealable, Including Denial of Related Motion to Dismiss and Discovery Finnegan
May
14
2021
Lack of Actual Reduction to Practice Sinks Nucleic Acid Sequencing Patents Finnegan
May
20
2021
Federal Circuit PTAB Appeal Statistics Through April 30, 2021 Finnegan
Jul
9
2021
Diverging Definitions: Is a Range Exclusive or Inclusive of the Endpoints? Finnegan
Jul
22
2021
Punctuation Pitfalls: Commas and Periods Kill Patents Finnegan
Sep
3
2021
Teaching Away May Preclude Motivation to Modify a Reference Finnegan
Sep
24
2021
A Look at AIA § 3(n)(2): Part Two of a Two-Part Series on AIA § 3(n) Effective Filing Date Provisions Finnegan
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins